If you own NuScale Power Corporation (NYSE: SMR) stock and purchased shares between May 13, 2025 and November 6, 2025, you may be part of a securities class action lawsuit—and April 20, 2026 is your deadline to become a lead plaintiff in the case. The lawsuit, filed in U.S. District Court for the District of Oregon as Truedson v.
NuScale Power Corporation, alleges that company executives made material misstatements and omissions regarding the company’s nuclear power commercialization strategy, particularly around a $495 million payment to a firm with minimal nuclear experience. Missing the April 20 deadline doesn’t necessarily prevent you from recovering damages as part of the class, but it eliminates your ability to serve as lead plaintiff and influence the litigation’s direction. This article explains what triggered the lawsuit, how much your investment may have been affected, what the April 20 deadline actually means for your situation, and what steps you should take if you believe you were harmed by NuScale’s disclosures.
Table of Contents
- What Triggered the NuScale Power Securities Class Action?
- Understanding the Financial Disclosure and Its Implications
- How the Stock Price Decline Affected Investors
- Understanding the Lead Plaintiff Deadline and What It Means for You
- What Happens After the April 20 Deadline?
- The Role of ENTRA1 and Partner Qualification Risks
- What Comes Next for NuScale Shareholders and the Nuclear Sector
What Triggered the NuScale Power Securities Class Action?
On November 6, 2025, NuScale Power disclosed a massive and unexpected jump in general and administrative expenses during its third quarter of 2025. The expenses surged from $17 million in the prior-year period to $519 million—an increase of more than 3,000%. The primary reason for this explosion was a $495 million payment to a company called ENTRA1 for services related to a Tennessee Valley Authority (TVA) agreement. However, according to the lawsuit allegations, ENTRA1 had never built, financed, or operated any significant projects in nuclear power generation, despite NuScale committing hundreds of millions in capital to this arrangement.
This disclosure created a disconnect between what investors thought NuScale’s commercialization strategy was and what actually occurred. The lawsuit contends that NuScale failed to adequately disclose the risks inherent in partnering with an inexperienced firm on such a capital-intensive project. The impact was immediate and severe: NuScale’s stock price declined approximately $5.45 per share (roughly 14.4%) following the November 6 announcement, representing a significant loss for shareholders who had purchased stock during the class period. The legal claims focus on violations of Securities Exchange Act Sections 10(b) and 20(a), which prohibit fraud and manipulation in securities trading. The lawsuit argues that NuScale’s executives made misstatements or omitted material facts about the company’s business strategy, particularly regarding the qualifications and track record of strategic partners.
Understanding the Financial Disclosure and Its Implications
The jump from $17 million to $519 million in G&A expenses is not a minor accounting adjustment—it represents a fundamental revelation about how NuScale was deploying its capital. For context, an increase of this magnitude would signal to any prudent investor that something significant had changed in the business model or strategy. However, if the company had previously communicated that it was exploring partnerships with firms in the nuclear sector, this disclosure might have been less shocking. The issue, according to the lawsuit, is that the disclosure came without adequate prior context about the risks of engaging an unproven partner. The ENTRA1 arrangement raises a practical concern for any large capital commitment: when a company outsources core strategic functions to a partner lacking relevant experience, execution risks multiply.
ENTRA1’s lack of nuclear power experience meant that NuScale was essentially betting hundreds of millions of dollars on a firm building expertise in real-time. This is different from partnering with an established nuclear contractor or a firm with a track record of successful project delivery. The distinction matters because it changes the probability of cost overruns, schedule delays, and project failure. One important caveat: the fact that a partner is inexperienced does not automatically mean fraud occurred. The issue is whether NuScale disclosed this inexperience clearly enough and whether it accurately characterized the risks to investors. The lawsuit alleges that NuScale failed on both counts—specifically, that it made misstatements or omissions regarding its commercialization strategy without acknowledging the challenges of working with an unproven partner on such a capital-intensive project.
How the Stock Price Decline Affected Investors
The 14.4% decline in NuScale’s stock price following the November 6 disclosure translates directly to financial losses for anyone holding shares during the class period (May 13–November 6, 2025). For example, if an investor purchased 1,000 shares at $37.80 per share and held through the November 6 announcement, they would have seen roughly $5,450 in losses when the stock fell to $32.35 per share. This loss is the foundation of the class action—investors claim they would not have purchased stock (or would have paid less) if they had known about the ENTRA1 partnership and NuScale’s inexperienced partner in a critical strategic initiative. The class period timing is specific: it begins on May 13, 2025 and ends on November 6, 2025. If you purchased NuScale stock at any point during this window, you are potentially part of the class.
This 177-day window captures the period when the company allegedly made misstatements or omitted material facts about its commercialization strategy. Anyone who bought or held stock before May 13, 2025 or after November 6, 2025 is not part of this particular class. The financial impact extends beyond just the stock price drop. Many investors may have held NuScale stock as part of a broader technology or energy portfolio, so the loss was one component of their overall investment decline during this period. Additionally, if an investor sold shares before November 6 believing the company was executing a sound strategy with qualified partners, they may have sold at prices that look overstated in hindsight.
Understanding the Lead Plaintiff Deadline and What It Means for You
The April 20, 2026 deadline is specifically for becoming the “lead plaintiff” in the class action lawsuit. Being the lead plaintiff means you would be the named representative for all other class members, and you would have significant influence over the litigation’s direction, settlement negotiations, and the selection of attorneys. The lead plaintiff role comes with additional responsibility but also ensures your interests are directly represented at the highest level. Only investors who file a motion by April 20, 2026 can be considered for this role. However, if you miss the April 20 deadline, you are not automatically barred from receiving compensation if the case settles or results in a judgment in favor of the class.
Instead, you would be a regular class member, meaning your recovery would be determined by the claims process established as part of any settlement or judgment. The key difference is that you would have less influence over how the case is litigated and what settlement terms are negotiated. Additionally, your recovery might be reduced slightly by administrative fees or legal fees that are deducted from the overall settlement amount. If you believe you were harmed by NuScale’s disclosures and you want to ensure your voice is heard throughout the litigation, the April 20 deadline is critical. You should consult with a class action attorney immediately, especially if you are considering filing for lead plaintiff status. Many law firms handling this case will evaluate whether your claim is substantial enough and your circumstances appropriate for lead plaintiff designation.
What Happens After the April 20 Deadline?
After April 20, 2026, the court will evaluate all lead plaintiff motions and select the individual or individuals who will serve as class representatives. This selection process is based on factors such as the size of your investment loss, your involvement and interest in the case, and your ability to represent the class fairly. Once lead plaintiffs are selected, the case moves forward with them as the named parties. Following lead plaintiff selection, the litigation typically enters the discovery phase, where both sides exchange documents, conduct depositions, and build their cases.
In a securities fraud case like this, discovery would focus on communications between NuScale executives regarding the ENTRA1 partnership, the due diligence process around selecting ENTRA1, internal assessments of ENTRA1’s capabilities, and what information was disclosed (or not disclosed) to investors. This phase can take many months or even years, depending on the complexity and the amount of information involved. Important to note: even if you miss the April 20 deadline, you should still monitor the case for settlement announcements or judgment outcomes. Once a settlement or judgment is reached, notice will be sent to all class members, and there will be a claims process through which you can submit proof of your purchases and losses. Missing the lead plaintiff deadline does not affect your eligibility to participate in this later process.
The Role of ENTRA1 and Partner Qualification Risks
One of the most striking aspects of the lawsuit is the allegation that NuScale committed $495 million to ENTRA1 without adequately disclosing that ENTRA1 had never built, financed, or operated significant nuclear power projects. In the energy sector, experience matters enormously because nuclear projects involve complex regulatory requirements, technical challenges, and cost pressures that can derail inexperienced operators. By comparison, if a utility hired a contractor with a 20-year history of successfully delivering nuclear infrastructure projects, the risk profile would be substantially different.
The allegation raises questions about NuScale’s due diligence and decision-making process. Why would the company select an inexperienced partner for such a mission-critical role? One possibility is that ENTRA1 offered unique technical expertise in a non-nuclear area that was relevant to the TVA agreement, or perhaps cost advantages were a factor. Without access to internal documents, we cannot know NuScale’s reasoning. However, the lawsuit contends that regardless of the reasoning, investors deserved to know that a key strategic partner lacked nuclear experience, particularly given that such experience is arguably essential for success in this industry.
What Comes Next for NuScale Shareholders and the Nuclear Sector
The outcome of this litigation could have ripple effects beyond just NuScale shareholders. If the case results in a substantial settlement or judgment against NuScale, it may signal to other nuclear companies and energy startups that disclosure standards around unproven partners and strategic risks are taken seriously by the courts. This could lead to more rigorous disclosures in future capital commitments to less-experienced firms.
Conversely, if NuScale successfully defends the case, it might suggest that companies have more flexibility in how they disclose partnership risks. For NuScale investors looking ahead, the key takeaway is that nuclear power is a capital-intensive, high-risk business where partner selection is critical. The company’s future success depends on whether the ENTRA1 partnership delivers results and whether NuScale can rebuild investor confidence through transparent communication about its commercialization strategy.